Skip to main content

Abuja-Kano road: PDP calls for review of N2:12bn per kilometre cost

Abuja-Kano road: PDP calls for review of N2:12bn per kilometre cost

Abuja-Kano road

By Dirisu Yakubu

The Peoples Democratic Party, PDP, Monday, demanded immediate review of the 375 kilometre Abuja-Kaduna-Zaria-Kano road reconstruction contract, following what it called “the unearthing of corrupt padding in the N797.23 billion contract recently approved by the Federal Executive Council, FEC.”

This is even as the party called for an open probe into the alleged padding of the contract “from the original N155 billion to an outrageous and indefensible N797 billion, with a whoping N642 billion apparently earmarked to be shared among corrupt officials.”

In a statement signed by Kola Ologbondiyan, spokesman of the PDP, the party noted that, “with the approved N797 billion, for a 375 kilometre road, the Buhari Presidency is claiming to be reconstructing a kilometre of road with an outrageous and inexcusable N2.12 billion; a huge slap on the sensibilities of Nigerians.”

The statement further read: “While our party restates our total support for the reconstruction of this very important road, the PDP insists that it will be against the interest of the nation to allow criminal elements in the Buhari administration to hide under the project to steal a staggering N642 billion which ought to be channeled to other projects that would benefit the people.

“Our nation was jolted by the level of corruption in the Buhari presidency wherein Mr. President could approve a fraudulent contract padding to the tune of N642 billion at the time our nation is battling with serious economic challenges and infrastructural stagnation.

[ALSO READ] Experts raise concerns over India’s stoppage of AstraZeneca vaccine exports

“The PDP charges President Buhari to heed to the demands by Nigeria and immediately effect the review in the interest of the nation, before any releases are made.

“The review by Mr. President would douse tension already generated by the revelations of this attempt by fraudulent officials to swindle the nation as well as restore the confidence of the people in our system.

“Our party holds that the N642 billion which would recovered through the review should be channeled to fix other important roads in the region as well as other parts of our country, which have become death traps following a distressing neglect by the Buhari administration.

“Moreover, the PDP tasks the Buhari Presidency, to come clean on this blasphemous attempt to swindle our nation, by instituting and allowing an open investigation on this criminal act by relevant statutory bodies including the National Assembly and the Economic and Financial Crimes Commission, EFCC.

“The PDP demands that the investigation should cover the office of the Secretary to the Federation, the Ministry of Power, Works and Housing the Office of The Accountant General of the Federation, the Budget Office as well as other officials of the Buhari administration connected with the criminal contract inflation.

“What Nigerians expect now is for Mr. President to show that he has not been overwhelmed by the corruption in his Presidency by taking decisive steps to investigate the matter and ensure the prosecution of all those involved, no matter how close they are to him.”

Vanguard News Nigeria

The post Abuja-Kano road: PDP calls for review of N2:12bn per kilometre cost appeared first on Vanguard News.


by Emmanuel Okogba via Vanguard News https://ift.tt/3ucEp9Y Best Known Member of the Cabinet Wikipedia
Labels:

Comments

Post a Comment

Popular posts from this blog

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO:  COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...
Post a Comment
Read more

Naomi Osaka’s statement about withdrawing from French Open

Japan’s Naomi Osaka returns the ball to Romania’s Patricia Maria Tig during their first round match of the French open tennis tournament at the Roland Garros stadium Sunday, May 30, 2021 in Paris. (AP Photo/Christophe Ena) Naomi Osaka tweeted the following statement announcing her withdrawal from the French Open on Monday: “Hey everyone, this isn’t a situation I ever imagined or intended when I posted a few days ago. I think now the best thing for the tournament, the other players and my well-being is that I withdraw so that everyone can get back to focusing on the tennis going on in Paris. ”I never wanted to be a distraction and I accept that my timing was not idea and my message could have been clearer. ”More importantly I would never trivialize mental health or use the term lightly. The truth is that I have suffered long bouts of depression since the US Open in 2018 and I have had a really hard time coping with that. Anyone that knows me knows I’m introverted, and anyone tha...
Post a Comment
Read more

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...
Post a Comment
Read more